HFS
AMED

Hantz Financial Services’s Amedisys AMED Stock Holding History

Hantz Financial Services’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-646
Closed -$64K – 2314
2025
Q2 		$64K Buy
+646
New +$61.1K ﹤0.01% 880
2023
Q3 		– Sell
-2,000
Closed -$183K – 1111
2023
Q2 		$183K Hold
2,000
– – ﹤0.01% 542
2023
Q1 		$147K Buy
+2,000
New +$173K ﹤0.01% 557

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hantz Financial Services's AMED Position: Q3 2025 in Review

Hantz Financial Services sold out of Amedisys (AMED) in Q3 2025, closing a stake of 646 shares — an estimated $64K sold.

Hantz Financial Services first reported a position in AMED in Q1 2023 and held it in 3 quarters. The position peaked at $183K in Q2 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Hantz Financial Services reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Hantz Financial Services sold 646 Amedisys shares in Q3 2025, an estimated $64K.
  • Hantz Financial Services first reported a position in Amedisys in Q1 2023 and held it in 3 quarters.
  • Hantz Financial Services's Amedisys position peaked at $183K in Q2 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Hantz Financial Services's 13F filing for Q3 2025, filed 5 Nov 2025.